GDF-8-INHIBITOREN

Patent europeic · EP3259264 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3259264
Numer da la dumonda
EP16711043
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
15-02-2016
Publitgà
27-12-2017
Concedì
27-07-2022
Stritgà
23-09-2023
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 401/14 (2006.01)
C07D 471/04 (2006.01)
C07D 487/04 (2006.01)
A61K 31/44 (2006.01)
A61P 21/00 (2006.01)
Prioritad
US 201562119052 P 20.02.2015
Dumonda PCT
PCT/US2016/017938 15.02.2016
Publicaziun PCT
WO2016/133838 25.08.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-09-2023

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.09.2023

  2. 07-06-2023

    Midada

    Published in Swissreg on 07.06.2023

  3. 27-07-2022

    Concedì

    Published in Swissreg on 27.07.2022

Partidas

Possessur

Rigel Pharmaceuticals, Inc.

1180 Veterans Boulevard, South San Francisco, CA 94080, US

Bristol-Myers Squibb Company

Route 206 and Province Line Road, Princeton, NJ 08543, US

Inventur

KINSELLA, Todd

Redwood City, CA 94061, US

BORZILLERI, Robert, M.

Princeton, NJ 08543, US

WARRIER, Jayakumar, Sankara

Bangalore 560 068, IN

SINGH, Rajinder

Belmont, CA 94002, US

BHAMIDIPATI, Somasekhar

Foster City, CA 94404, US

DING, Pingyu

Foster City, CA 94404, US

RAHAMAN, Hasibur

Bangalore 560 100, IN

GELMAN, Marina

San Francisco, CA 94121, US

VELAPARTHI, Upender

Wallingford, CT 06492, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.